Accelerating Typhoid Conjugate Vaccine Introduction

This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.

Corporate author(s): Typhoid Vaccine Acceleration Consortium

Publication date: June 2018

Available materials

  1. English

    1. Accelerating Typhoid Conjugate Vaccine Introduction - PDF

      Hard copies are not available.

  2. French

    1. Accelerating Typhoid Conjugate Vaccine Introduction - PDF

      Hard copies are not available.